This article was originally published on Fool.com
Investors are flooding intocannabis stocks, and plenty of companies that hardly anyone had ever heard of just a year ago have now become some of the best-known names in the marijuana space.Canadas legalization of recreational marijuanahas pulled stocks that operate north of the 49th parallel into the spotlight, andCanopy Growth(NYSE:CGC)has become one of the early-moving leaders of this budding industry.
Many think that Canopy Growths best days might well be behind it. After all, the stock has already seen shares jump more than 20-fold on the Toronto Stock Exchange since mid-2016, and its posted impressive gains in the few months that its traded on the New York Stock Exchange as well. But thanks in large part to anearly $4 billion investmentfrom Corona beer makerConstellation Brands(NYSE:STZ)as well as its own strategic vision for marijuana dominance, the future for Canopy Growth still looks bright.
What Canopy can do on its own
Even before Constellation upped the ante by boosting its stake in the marijuana grower, Canopy had a number of things going for it that gave it a competitive advantage over most players in the industry.Canopy already has huge production capacity, having reported about 2.4 million square feet of licensed growing space for cannabis as of mid-2018. Moreover, the company is investing heavily in boosting production, with new greenhouses in key areas like British Columbia potentially more than doubling its square footage to a goal of 5.7 million square feet. Once fully online, that could bring Canopys dried cannabis production capacity into a range of roughly 450,000 to 500,000 kilograms, and that would leave it as either the industry leader or a close second based on current planned investments elsewhere in the sector.
Moreover, unlike many cannabis companies, Canopy was smart early on in recognizing the value of diversifying its geographical scope. Rather than simply building distribution networks in Canada, Canopy already has a presence in several foreign markets, and the ability to export cannabis gives the company the ability to avoid price challenges in its home market to find the best profit opportunities worldwide.
Canopy has also seen the importance of building a brand. The companys Tweed line of products goes well beyond dried marijuana leaf to encompass growth areas like softgel capsules for cannabis-derived oils. And even under Canadas plain-packaging laws, Tweed has the ability to develop a loyal customer base that will give Canopy the ability to market value-added products with higher margin levels than plain dried cannabis.
Canopy and Constellation
Yet the biggest vote of confidence in Canopy Growth has come from Constellation Brands. The alcohol specialist has made multiple investments in Canopy, starting with a nearly 10% stake a year ago for $190 million and thendoubling down with its $3.8 billion deal this past August. Under the terms of the deal, Constellation not only boosted its interest in Canopy to 38%, it also gave itself the option to boost its stake in Canopy if it chooses to exercise its rights on warrants and convertible debt to accept additional shares of the marijuana producer.
The opportunities for Canopy and Constellation to collaborate have huge potential. A number of companies are already exploring the potential forbeverages that incorporate various cannabis-derived oils, emphasizing both the positive health impacts of certain types of oils and the popularity of cannabis in general. Just as energy drinks reinvigorated a flagging market for traditional sugary carbonated soft drinks, so too could marijuana-containing beverages bring new interest to the industry.
Constellation also likely sees the collaboration as a defensive measure. Some cannabis advocates have played up the advantages of marijuana over alcohol. If consumers substitute cannabis for beer and spirits, then its useful for Constellation to have exposure to both industries while still potentially leaving Canopy stock available for investors who want purer exposure to the cannabis sector.
A play on innovation
Finally, Canopy understands that it needs to foster innovation in order to stay ahead of the game. Thats a big part of why it funded theCanopy Rivers investment vehicle, and already, its found some lucrative investments that could pay off for Canopy Growth in the future.
Canopy Growth has already seen impressive gains for early shareholders, and its reasonable for investors to highlight both risks and potential rewards from investing in the stock. Yet from a fundamental business perspective, thebest days for Canopy Growthlie squarely in front of it.
With recreational and medicinal cannabis use now fully legal throughout Canada (not to mention in 30 US states to varying degrees), we think now could be the perfect time to start adding cannabis stocks to your own portfolio as the Green Rush gathers speed!
To help you navigate the potential risks and rewards, The Motley Fools leading cannabis sector analyst has put together this timely special report explaining what we think every UK investor needs to know about this exciting profit opportunity and reveals one cannabis stock that we reckon youll want to cross off your shopping list right away!